Dr. Francesca Bagnato is a dual-board (European and American) neurology certified physician, currently on faculty at Vanderbilt University Medical Center (VUMC). Dr. Bagnato sees patients with neuroimmunological diseases at the Neuroimmunology Clinic of VUMC as well as the Nashville VA HealthCare System. She joined Vanderbilt in October 2015 where she is now the Head of the Neuroimaging Program of the Neuroimmunology Division, Co-Director of Research-MSCoE-East for the VA and Associate Vice-Chair of Research at VUMC. Dr. Bagnato has authored more than 100 publication focused on MS.
Jiacheng Wang is a second-year Ph.D. student at Vanderbilt University majoring in computer science in Prof Oguz lab. He is passionate about exploring the potential application of machine learning/deep learning in physiological and pathological conditions.
Jiacheng runs several projects aimed at developing automated segmentation of paramagnetic rim lesions, leptomeningeal enhancement foci and white matter lesions on 7T MRI under limited human annotations scenarios.
Taegan has her B.S. in Public Health from the University of Alabama. Taegan enrolls participants, obtains consent, and assists with 7T MRI scans. Taegan is interested in gaining further knowledge in the progression of multiple sclerosis observed through MRI methods and performs image analyses of mice with experimental multiple sclerosis.
Caroline graduated from Belmont University with her B.S in biology and psychology. Caroline follows alongside patients through the research process by working to recruit patients and assist with their MRIs. She hopes to learn more about the progression and functioning of multiple sclerosis through the use of MRI technology.
Dr. Carynn Koch completed her undergraduate education at University of Southern Indiana and medical education at the Indiana University School of Medicine. She then joined Vanderbilt University Medical Center, where she trained in neurology and served as Chief Neurology Resident during her last year. Dr. Koch is a clinical fellow sponsored by the National MS Society, with plans to pursue a career in the comprehensive management of multiple sclerosis. Dr. Koch is also engaged in a research project studying the longitudinal outcome of lesions with and without a central vein sign.